Certified by Founder Lodge
EcoR1 Capital, LLC
United States - San Francisco Bay Area
INVESTOR
1 Disclosed Funding Rounds $50,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
EcoR1 Capital, LLC is a biotech focused investment advisory firm.
| Company | Date | Round | Raised |
|---|---|---|---|
 ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
 Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
 Scorpion Therapeutics |
July, 17 ,2024 | Series C | $150,000,000 |
 Diagonal Therapeutics |
January, 13 ,2026 | Series B | $125,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Allos | $5,000,000 | (Jan 14, 2026)
PayMedix | $33,000,000 | (Jan 14, 2026)
JetZero | $175,000,000 | (Jan 14, 2026)
Converge Bio | $25,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
